Patients with Atrial Fibrillation in Clinical Practice: Comorbidity, Drug Treatment and Outcomes (Data from RECVASA Registries)

Patients with Atrial Fibrillation in Clinical Practice: Comorbidity, Drug Treatment and Outcomes (Data from RECVASA Registries)

Aim. To study comorbidity, drug therapy and outcomes in patients with atrial fibrillation (AF) included in the outpatient and hospital RECVASA registries.Material and methods. Patients with AF (n=3169; age 70.9±10.7 years; 43.1% of men) in whom comorbidity, drug therapy, short-term and longterm outc...

Full description

Bibliographic Details
Main Authors: M. M. Loukianov, E. Yu. Andreenko, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, E. Yu. Okshina, V. V. Yakusevich, V. Vl. Yakusevich, E. M. Pozdnyakova, T. A. Gomova, E. E. Fedotova, M. N. Valiakhmetov, V. P. Mikhin, Yu. V. Maslennikova, V. G. Klyashtorny, E. V. Kudryashov, Ju. E. Tatsii, S. A. Boytsov, O. M. Drapkina
Format: Article
Language:English
Published: Stolichnaya Izdatelskaya Kompaniya 2020-12-01
Series:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:
atrial fibrillation
outpatient and hospital registries
comorbidity
drug treatment
prospective monitoring
outcomes
mortality
Online Access:https://www.rpcardio.com/jour/article/view/2349

Internet

https://www.rpcardio.com/jour/article/view/2349

Similar Items